Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers.

PURPOSE To determine whether bladder cancer is associated with exposure to perfluorooctane sulfonate (PFOS) in an occupational cohort. METHODS Incidence of bladder cancer was ascertained by postal questionnaire to all living current and former employees of the facility (N = 1895) and death certificates for deceased workers (N = 188). Exposure to PFOS was estimated with work history records and weighted with biological monitoring data. Standardized incidence ratios (SIRs) were estimated using U.S. population-based rates as a reference. Bladder cancer risk within the cohort was evaluated using Poisson regression by cumulative PFOS exposure. RESULTS Questionnaires were returned by 1,400 of the 1895 cohort members presumed alive. Eleven cases of primary bladder cancer were identified from the surveys (n = 6) and death certificates (n = 5). The SIRs were 1.28 (95% confidence interval [CI] = 0.64-2.29) for the entire cohort and 1.74 (95% CI = 0.64-3.79) for those ever working in a high exposed job. Compared with employees in the lowest cumulative exposure category, the relative risk of bladder cancer was 0.83 (95% CI = 0.15-4.65), 1.92 (95% CI = 0.30-12.06), and 1.52 (95% CI = 0.21-10.99). CONCLUSIONS The results offer little support for an association between bladder cancer and PFOS exposure, but the limited size of the population prohibits a conclusive exposure response analysis.

[1]  Harvey J Clewell,et al.  Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives. , 2006, Toxicology.

[2]  N. Pearce,et al.  Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons , 1989, International journal of cancer.

[3]  Andrea Pfahles-Hutchens,et al.  The Applicability of Biomonitoring Data for Perfluorooctanesulfonate to the Environmental Public Health Continuum , 2006, Environmental health perspectives.

[4]  Jeffrey H Mandel,et al.  Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.

[5]  Jeffrey H Mandel,et al.  An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring. , 2003, AIHA journal : a journal for the science of occupational and environmental health and safety.

[6]  Jeffrey H Mandel,et al.  Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations , 2003, Journal of occupational and environmental medicine.

[7]  G. Olsen,et al.  Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  A. Seacat,et al.  Interactions of fluorochemicals with rat liver fatty acid-binding protein. , 2002, Toxicology.

[9]  K. Hansen,et al.  Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. , 2001, Environmental science & technology.

[10]  B H Alexander,et al.  Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility , 2003, Occupational and environmental medicine.

[11]  J. Hopkins.  IARC Monographs on the evaluation of carcinogenic risks to humans: Volume 48. Some flame retardants and textile chemicals, and exposures in the textile manufacturing industry , 1991 .

[12]  E. Cardis,et al.  Bladder cancer and occupational exposures. , 1994, Scandinavian journal of work, environment & health.

[13]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[14]  M S Christian,et al.  Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. , 2001, International journal of toxicology.

[15]  R. G. York,et al.  Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. , 2005, Toxicology.

[16]  M. Hauptmann,et al.  Cancer incidence in the U.S. radiologic technologists health study, 1983–1998 , 2003 .

[17]  S. Porru,et al.  Bladder cancer and occupation: a case-control study in northern Italy. , 1996, Occupational and environmental medicine.

[18]  C. Elcombe,et al.  Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. , 2003, Toxicology.

[19]  C. Hogstedt,et al.  Urothelial cancer and some industry-related chemicals: an evaluation of the epidemiologic literature. , 1990, American journal of industrial medicine.

[20]  A. Ruder,et al.  Industries and cancer , 1997, Cancer Causes & Control.

[21]  Timothy R. Church,et al.  Quantitative Evaluation of Perfluorooctanesulfonate (PFOS) and Other Fluorochemicals in the Serum of Children , 2004 .

[22]  Deborah Schrag,et al.  Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. , 2005, Journal of the National Cancer Institute.

[23]  Nathan M. Bass,et al.  Interactions of flurochemicals with rat liver fatty acid-binding protein , 2002 .

[24]  H. Ozen.  Bladder cancer. , 1998, Current opinion in oncology.

[25]  Jeffrey H Mandel,et al.  Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. , 2004, Chemosphere.

[26]  M. Stanton,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  V. Cogliano.  International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.

[28]  H. Anton-Culver,et al.  Occupation and bladder cancer risk. , 1992, American journal of epidemiology.

[29]  Jeffrey H Mandel,et al.  Analysis of Episodes of Care in a Perfluorooctanesulfonyl Fluoride Production Facility , 2004, Journal of occupational and environmental medicine.

[30]  P. Boffetta,et al.  Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons , 1997, Cancer Causes & Control.

[31]  A. Calafat,et al.  Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. , 2006, Environmental science & technology.

[32]  Derek C G Muir,et al.  Biological monitoring of polyfluoroalkyl substances: A review. , 2006, Environmental science & technology.

[33]  N. Weiss.  Cancer in relation to occupational exposure to perchloroethylene , 1995, Cancer Causes & Control.

[34]  N. E. Breslow.  Statistical Methods in Cancer Research , 1986 .

[35]  P. Vineis,et al.  Aromatic amines and cancer , 1997, Cancer Causes & Control.